[
  {
    "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Participants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  }
]